Multiple endocrine neoplasia, type II: a combined surgical and genetic approach to treatment.

A family with multiple endocrine neoplasia, type II living in southeastern Ontario is described. Twenty individuals are known to have had medullary carcinoma of the thyroid, pheochromocytoma or both, the diagnosis of multiple endocrine neoplasia. type II is strongly suspected in five other individuals in the earlier generations. In this family the diseases seems to be transmitted by an autosomal dominant gene. A screening program set up for the family in 1977 has in 2 years identified four asymptomatic individuals (three with medullary carcinoma of the thyroid and one with this carcinoma and a pheochromocytoma). The family background, clinical picture, treatment and some of the problems of the screening program are described.

[1]  L. Leape,et al.  Natural history of familial medullary thyroid carcinoma: effect of a program for early diagnosis. , 1978, The New England journal of medicine.

[2]  W. Sturtridge,et al.  Calcium infusion and pentagastrin injection in diagnosis of medullary thyroid carcinoma. , 1978, Canadian Medical Association journal.

[3]  A. Miller.  Present status of breast cancer screening. , 1977, Canadian Medical Association journal.

[4]  B. Pasternack,et al.  Breast neoplasms in women treated with x-rays for acute postpartum mastitis. , 1977, Journal of the National Cancer Institute.

[5]  R. Monson,et al.  Breast cancer in women after repeated fluoroscopic examinations of the chest. , 1977, Journal of the National Cancer Institute.

[6]  G. Beebe,et al.  Breast cancer incidence among atomic bomb survivors, Hiroshima and Nagasaki, 1950-69. , 1977, Journal of the National Cancer Institute.

[7]  J. F. Hennessy,et al.  A comparison of pentagastrin injection and calcium infusion as provocative agents for the detection of medullary carcinoma of the thyroid. , 1974, The Journal of clinical endocrinology and metabolism.

[8]  S. Wells,et al.  Familial medullary carcinoma of the thyroid, adrenal pheochromocytoma and parathyroid hyperplasia. A syndrome of multiple endocrine neoplasia. , 1973, Radiology.

[9]  J. Doppman,et al.  Sipple's syndrome: medullary thyroid carcinoma, pheochromocytoma, and parathyroid disease. Studies in a large family. NIH conference. , 1973, Annals of internal medicine.

[10]  S. Cutler,et al.  Increasing incidence and decreasing mortality rates for breast cancer , 1971, Cancer.

[11]  L. Deftos.  Immunoassay for human calcitonin. I. Method. , 1971, Metabolism: clinical and experimental.

[12]  A. Tashjian,et al.  Early diagnosis of medullary carcinoma of the thyroid gland by means of calcitonin assay. , 1971, The New England journal of medicine.

[13]  A. Tashjian,et al.  Immunoassay of human calcitonin. , 1970, The New England journal of medicine.

[14]  W. Mcleish,et al.  Pheochromocytoma and medullary carcinoma of thyroid , 1968, Cancer.

[15]  S. Lindsay,et al.  Medullary carcinoma of the thyroid gland. , 1965, Archives of pathology.

[16]  Report of the Working Group to Review the National Cancer Institute-American Cancer Society Breast Cancer Detection Demonstration Projects. , 1979, Journal of the National Cancer Institute.

[17]  J C Bailar,et al.  Mammography: a contrary view. , 1976, Annals of internal medicine.

[18]  A. Tashjian,et al.  Possible linear order of genes for endocrine neoplasia type 2, the P red cell antigen and HL-A on chromosome 6. , 1976, Birth defects original article series.

[19]  M. Telenius‐Berg.  Diagnostic studies in medullary carcinoma of the thyroid. New methods for early diagnosis in families with Sipple's syndrome. , 1976, Acta medica Scandinavica. Supplementum.

[20]  V. Go,et al.  Stimulation tests for diagnosis of medullary thyroid carcinoma. , 1975, Mayo Clinic proceedings.